Goltz D, Fischer H-P
Pathologe. 2015 Nov;36(6):597-606; quiz 607-8. doi: 10.1007/s00292-015-0113-0.
In recent years, the spectrum of tissue-based diagnostics of hepatocellular tumours has changed due to novel molecular pathological findings. Innovative radiographics filter out small lesions and ambiguous tumours for bioptical sampling. The spectrum of these tumours includes hepatocellular carcinoma, hepatocellular adenomas, focal nodular hyperplasia and macroregenerative nodules. Primarily, morphological analysis should identify the dignity of a lesion. After exclusion of HCC and reactive liver cell nodules, hepatocellular adenomas should be further subclassified based on immunohistochemical/molecular pathological criteria according to the WHO classification of liver tumours. This procedure provides significant additional information regarding the prognosis and therapeutic implications of hepatocellular adenomas.
近年来,由于新的分子病理学发现,肝细胞肿瘤基于组织的诊断范围发生了变化。创新的放射影像学技术可筛选出小病变和不明确的肿瘤进行活检取样。这些肿瘤包括肝细胞癌、肝细胞腺瘤、局灶性结节性增生和大再生结节。首先,形态学分析应确定病变的性质。排除肝细胞癌和反应性肝细胞结节后,应根据世界卫生组织肝脏肿瘤分类,依据免疫组织化学/分子病理学标准对肝细胞腺瘤进行进一步分类。这一程序为肝细胞腺瘤的预后和治疗意义提供了重要的额外信息。